TPM for business operations in fast-paced, high-growth Medical Device Start-up. Implement Change Management Process for multiple Business Operations IT teams. Improved visibility of on-going work by 80% through Jira Implementation. Primary Program Manager for Netsuite implementation (9 months E2E). Manage co-development ERP project with global external partners. Netsuite Integrations Coordinator with seven, independent third-party softwares: Bill.com, Arena QMS, NiceLabel, UPS, USPS, FedEx, SalesforceDraft and maintain project documentation including Timelines, Meeting Minutes, Project Plans, Invoices, Budgets, Business and Technical Requirements, Statements of Work, Business Associate Agreements, NDAs.

Lead Scientist, Scrum Master, and Product Owner for digital pathology solution in assay development,overseeing the seamless integration of two hardware systems (diagnostic platform and imaging platform),two software platforms, and digital algorithm for external contract.

Delegate and coordinate project deliverable activities, optimizing team productivity and meeting projectmilestones. Management methods ensured on-time delivery of project milestones.Trained technical team in Roche PDP, technical methods, and SAFe Agile/Scrum, fostering a highly efficient and collaborative work environment.Drafted and reviewed test protocols, and reports. Performed data analysis and reviewed documentation for quality.

Lead workstream to deliver cost per test improvement for Ventana Instruments. Collaborated with subject matter experts, performed literature reviews and data analysis, drafted and presented proposal to leadership team. Savings for customer is upwards of $70,000/yearScrum Master for cross-functional team of ten. Organize and lead project increment and sprint planning sessions. Create and maintain feature backlogs and create schedules aligning with business priority. Regularly communicate with partnering scrum teams to align on resource allocation. Research, draft, and present risk and requirement summaries for technical and business audiences. Improved meeting efficiency by 75% by implementing document pre-read activities and effective presentation methods for varied audience. Collaborators include: Global Customer Support, Marketing, Regulatory, Project Leads, Technical Teams, Operations, Development Team, Quality Engineering, Project Management

Designed and matured Design Assurance Testing Strategy to ensure quality and robust product deliverable (Hardware emphasis). Lead testing implementation to ensure complete traceability for MDSAP Compliance. Communicated strategy to project leads, coordinated testing timelines for engineers and scientists.Lead monthly meetings to encourage innovation through guest speakers, senior design team updates, summer intern projects, and side-projects. This provided an engaging platform for peers to challenge and create new solutions for current platform issues. Lead Researcher for CAPA investigation. Determined root cause by performing tissue analysis for chemical staining compatibility. Draft, execute, and complete test plans for On-Market Support. Consulted with other departments such as Biostatistics for sample size and data analysis recommendation. Communicated results through report writing and technical assessments. Refined pathology technical skills: pathology scribe for advanced staining, histopathology techniques, spinning disc confocal microscopy, digital pathology

Developed an independent project to determine efficacy of various extra cellular matrix substrates by performing literature reviews to evaluate established methods of myoblast cultures in the field and analysis methods such as ELISA assay.

Dr. Hanna Fares LabLysosomes are membrane-bound organelles that serve as the major degradative compartments for endocytic, phagocytic, and autophagic materials targeted for destruction in eukaryotic cells. This degradation is critical to many physiological processes, including processing endocytosed nutrients, down-regulating signaling receptors, presenting antigens, killing pathogenic organisms, and degrading normal and abnormal cellular proteins. In addition, lysosomes mediate some cell death pathways and repair damage to the plasma membrane. Lysosomes are formed in complex eukaryotes by the budding of a small nascent lysosome from a late endosome/hybrid organelle, movement of the nascent lysosome away from the hybrid organelle while maintaining a membrane bridge, and scission of the membrane bridge to release a discrete primary lysosome. We had previously identified the Mucolipidosis type IV protein TRPML1 as a regulator of the scission step during lysosome formation. We describe the identification of additional regulators of this process, including actin that provides the force for moving nascent lysosomes away from late endosomes/hybrid organelles.

Dr. Serrine Lau's Lab